Indian vaccine maker Bharat Biotech is aiming to start clinical trials in the country for its Covaxin, which reportedly demonstrated 81 percent interim efficacy in preventing COVID-19 in individuals without prior infection after the second dose, company officials said yesterday.
Full Post on Source: Indian vaccine maker to start clinical trials in Philippines
